The core problem and therapeutic approach
In diabetes mellitus, the body faces a condition of persistent, chronic elevation of blood glucose levels. Of particular concern is postprandial hyperglycemia—a sharp spike in sugar concentration that occurs immediately after consuming a carbohydrate-rich meal.
To control this condition, the drug Glucobay is used, with its active ingredient being acarbose. Chemically, this compound is a pseudotetrasaccharide. The main task of acarbose is to act as an inhibitor of enzymes responsible for carbohydrate digestion in the gastrointestinal tract.
Normal carbohydrate digestion pathway
To understand the logic behind these inhibitors, it is necessary to examine in detail the normal biochemical cascade of carbohydrate hydrolysis in the intestine. The process occurs in several stages involving specific enzymes:
- Polysaccharide breakdown: Starch and glycogen are broken down by pancreatic alpha-amylase into shorter fragments—dextrins, as well as disaccharides (maltose and isomaltose).
- Maltose hydrolysis: The disaccharide maltose is broken down into two free glucose molecules with the participation of the enzyme maltase.
- Isomaltose hydrolysis: Isomaltose, under the action of isomaltase, also yields two glucose molecules.
- Sucrose hydrolysis: The enzyme sucrase breaks down sucrose into glucose and fructose.
- Lactose hydrolysis: Under the influence of lactase, milk sugar (lactose) breaks down into glucose and galactose.
Mechanism of action of acarbose
Acarbose performs competitive inhibition. This means that the drug molecule is structurally very similar to the natural substrate (oligosaccharide). Due to this similarity, acarbose binds to the active sites of enzymes, blocking access for real dietary carbohydrates.
The main target of the drug is the alpha-glucosidase complex, which is localized on the brush border of enterocytes (small intestine cells). The enzymes most sensitive to the drug include:
- Glucoamylase
- Sucrase
- Maltase
To a somewhat lesser extent, the drug can inhibit the activity of pancreatic alpha-amylase. As a result, the enzymatic breakdown of polysaccharides and oligosaccharides in the lumen of the small intestine is reliably blocked.
Biochemical and clinical result
Blockade of the brush border enzymes triggers a sequential chain of favorable biochemical changes. Because complex carbohydrates cannot be rapidly broken down into monosaccharides, the release of free glucose from the food bolus is slowed down.
Consequently, the rate of glucose absorption into the bloodstream drops significantly. Clinically, this means that the peak blood sugar concentration is blunted, and postprandial hyperglycemia is effectively reduced. The body avoids sharp carbohydrate surges after meals, which is critical for managing diabetes mellitus.
Briefly: answers to topical questions
What typical side effects occur when taking alpha-glucosidase inhibitors?
When taking alpha-glucosidase inhibitors, dyspeptic disorders are typical:
- flatulence;
- diarrhea.
They occur due to the fermentation of undigested carbohydrates by the intestinal microflora.
Acarbose works like a "fake carbohydrate" (pseudotetrasaccharide): it takes up space on the enzyme, so real sugar from food is forced to "wait in line" and is absorbed into the blood much slower, without sharp spikes.
Class and exam questions
What is postprandial hyperglycemia?
This is a sharp increase in the concentration of free glucose in the blood that occurs immediately after a meal.
Why is acarbose a competitive inhibitor?
Because the drug molecule mimics the natural substrate (oligosaccharide) in its structure and directly competes with it for binding to the active site of the enzyme.
Which enzymes are primarily blocked by this drug?
Acarbose primarily inhibits the alpha-glucosidase complex on the brush border of enterocytes, which includes glucoamylase, sucrase, and maltase.
How do alpha-glucosidase inhibitors affect glucose absorption?
They do not completely prevent absorption, but significantly slow down the process of glucose release from food, blunting the peak of its concentration in the blood.
What else to study on this topic
- Structural features of pseudotetrasaccharides
- Functioning of the enzymatic brush border complex of enterocytes
- Specificity of action of pancreatic alpha-amylase
- Biochemical differences in the hydrolysis of various disaccharides (sucrose, lactose, maltose)
Master the entire topic in the "Biochemistry" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Diabetes Mellitus and Alpha-Glucosidase Inhibitors" and 3,616 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 115 video lessons on the subject
Other topics in the section "Carbohydrate Metabolism"
Free video lessons: biochemistryShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.